Of: Anna Mia Ekström, Anna Sjöblom, Christina Franzén, Claes Ånstrand, Farhad Mazi Esfahani, Frida Sandegård, Gunilla Källenius, Mari Mörth, Maria Andersson, Mikaela Hildebrand and Tobias Alfvén
Every year, AIDS, tuberculosis and malaria cause the deaths of three million people. The challenges are many, but there is still hope of achieving the UN goal of stopping these diseases by 2030. In two weeks, world leaders will announce how much contribution they are willing to make to the Global Fund against AIDS, Tuberculosis and Malaria in the next three-year period. It is time for a gathering of forces, write representatives of RFSU, RFSL, Médecins Sans Frontières, the Swedish Medical Association's Committee for Global Health, the World Infection Fund, Karolinska Institutet and HIV-Sweden.
September 9, 2016, Debate
Of: Claes Ånstrand, Gunilla Källenius and Knut Lönnroth
Sweden has chosen to reduce support for the fight against one of the world's deadliest diseases - tuberculosis. With a looming pandemic of multi-resistant tuberculosis, this is difficult to understand. The World Health Organization aims to reduce the number of tuberculosis patients by 90 percent by 2035, but then large research investments and new forms of collaboration are required. It is written by Gunilla Källenius, Knut Lönnroth and Claes Ånstrand.
June 30, 2016, Debate
Of: Gun-Britt Andersson, Johan Hassel and Rosanna Färnman
Sweden has long emerged as a major power in health care. We have also taken on a leadership role in order to achieve the lofty goals in Agenda 2030. At the same time, the government is now reducing its funding for health assistance, write three debaters from the think tank Global Challenge.
February 22, 2016, Debate
AIDS, tuberculosis and malaria affect millions of poor people around the world. Despite this, the Swedish government wants to reduce support for the Global Fund, which fights the three diseases. The reduced funding is a threat to our ability to stop the epidemics, 159 organizations write in an open letter to Stefan Löfven.
February 4, 2016, Debate
Of: Claes Ånstrand, Gunilla Källenius, Johan Mast, Judith Bruchfeld, Knut Lönnroth and Olle Stendahl
Every year, 9 million people get tuberculosis. During the same period, 1,5 million people die from the disease. Research on new diagnostic methods and drugs is not a priority. Large pharmaceutical companies tend to pull out instead of investing more. Sweden has all the prerequisites to become the strong voice needed to prioritize the fight against tuberculosis. That is the opinion of Judith Bruchfeld, Gunilla Källenius, Knut Lönnroth, Olle Stendahl, Claes Ånstrand and Johan Mast.
November 25, 2014, Debate
Of: Anders Molin
Much of Björn Ekman's criticism of global health assistance is correct, but one must see nuances beyond black and white. Anders Molin writes in a reply.
November 6, 2014, Debate
Of: Björn Ekman
Sida's claim that the Global Fund's and GAVI's efforts would be “well integrated in the recipient countries 'health systems where the starting point is the countries' own needs and priorities” lacks strong support. These and other major donors have built up special systems for HIV / AIDS support, which are separate from the countries' own systems. The donors have not done enough to increase the effectiveness of aid or reduce the burden of aid on the recipient countries, Björn Ekman writes in a reply.
November 4, 2014, Debate
Of: Anders Molin
At the same time as the outside world's health investments have made it difficult for the recipient countries to plan and manage their own healthcare, the resources have saved millions of lives. This is what Anders Molin, Sida's expert on health assistance, writes in a reply to Björn Ekman.
October 30, 2014, Debate
Of: Björn Ekman
The parallel, bureaucratic structures that have emerged in international health assistance mean that the support of the outside world can be directly detrimental to the recipient countries' conditions for development. No more fragmented efforts are needed to deal with the Ebola epidemic, efforts based on knowledge and needs are needed. That is the opinion of Björn Ekman, a researcher at Lund University
October 28, 2014, Debate
Of: Gunilla Källenius and Olle Stendahl
In recent years, the reduction in budget allocations for Swedish research on global health issues is ominous, not least against the background of poverty diseases such as HIV / AIDS and Ebola. The new government now has the chance to take seriously the hitherto unfulfilled parliamentary promise from 2006 to contribute to the global fight against infectious diseases by further developing Swedish research. That is the opinion of Gunilla Källenius and Olle Stendahl
October 15, 2014, Debate
